Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2009 2
2010 2
2011 3
2012 5
2013 8
2014 5
2015 8
2016 7
2017 5
2018 12
2019 9
2020 6
2021 10
2022 9
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Immune Intervention for Type 1 Diabetes.
Nambam B, Bratina N, Schatz D. Nambam B, et al. Among authors: bratina n. Diabetes Technol Ther. 2018 Feb;20(S1):S86-S93. doi: 10.1089/dia.2018.2507. Diabetes Technol Ther. 2018. PMID: 29437480 Review. No abstract available.
Immune Intervention in Type 1 Diabetes.
Nambam B, Bratina N, Schatz D. Nambam B, et al. Among authors: bratina n. Diabetes Technol Ther. 2019 Feb;21(S1):S95-S100. doi: 10.1089/dia.2019.2507. Diabetes Technol Ther. 2019. PMID: 30785317 Review. No abstract available.
Immune Intervention in Type 1 Diabetes.
Nambam B, Bratina N, Schatz D. Nambam B, et al. Among authors: bratina n. Diabetes Technol Ther. 2020 Feb;22(S1):S141-S148. doi: 10.1089/dia.2020.2511. Diabetes Technol Ther. 2020. PMID: 32069151 Review. No abstract available.
Immune Interventions for Type 1 Diabetes Mellitus.
Nambam B, Bratina N, Schatz D. Nambam B, et al. Among authors: bratina n. Diabetes Technol Ther. 2017 Feb;19(S1):S74-S81. doi: 10.1089/dia.2017.2507. Diabetes Technol Ther. 2017. PMID: 28192018 Review. No abstract available.
A new horizon for glucose monitoring.
Dovč K, Bratina N, Battelino T. Dovč K, et al. Among authors: bratina n. Horm Res Paediatr. 2015;83(3):149-56. doi: 10.1159/000368924. Epub 2015 Feb 5. Horm Res Paediatr. 2015. PMID: 25660230 Free article. Review.
The Role of Epigenetic Modifications in Late Complications in Type 1 Diabetes.
Čugalj Kern B, Trebušak Podkrajšek K, Kovač J, Šket R, Jenko Bizjan B, Tesovnik T, Debeljak M, Battelino T, Bratina N. Čugalj Kern B, et al. Among authors: bratina n. Genes (Basel). 2022 Apr 15;13(4):705. doi: 10.3390/genes13040705. Genes (Basel). 2022. PMID: 35456511 Free PMC article. Review.
Immune Intervention in Type 1 Diabetes.
Nambam B, Bratina N, Chatz D. Nambam B, et al. Among authors: bratina n. Diabetes Technol Ther. 2022 Mar;24(S1):S184-S189. doi: 10.1089/dia.2022.2512. Diabetes Technol Ther. 2022. PMID: 35475689 No abstract available.
Paediatric screening for hypercholesterolaemia in Europe.
Kusters DM, de Beaufort C, Widhalm K, Guardamagna O, Bratina N, Ose L, Wiegman A. Kusters DM, et al. Among authors: bratina n. Arch Dis Child. 2012 Mar;97(3):272-6. doi: 10.1136/archdischild-2011-300081. Epub 2011 Sep 26. Arch Dis Child. 2012. PMID: 21949015 Review.
Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience.
Witsch M, Kosteria I, Kordonouri O, Alonso G, Archinkova M, Besancon S, Birkebæk NH, Bratina N, Cherubini V, Hanas R, Hasnani D, Iotova V, Raposo JF, Schwandt A, Sumnik Z, Svensson J, Veeze H; SWEET Group. Witsch M, et al. Among authors: bratina n. Pediatr Diabetes. 2016 Oct;17 Suppl 23:7-15. doi: 10.1111/pedi.12432. Pediatr Diabetes. 2016. PMID: 27982492 Review.
80 results